metoprolol has been researched along with Elevated Cholesterol in 6 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study effects of fosinopril on a 24-h profile of blood pressure (BP) in hypertensive patients with obesity and hypercholesterolemia." | 9.11 | [Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia]. ( Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM, 2005) |
| " The aim of this study was to test the hypothesis that the beta-blocker metoprolol succinate controlled release/extended release (CR/XL), when given to patients with hypercholesterolemia on concomitant lipid-lowering therapy, provides an additional antiatherosclerotic effect to that provided by the statins, measured as carotid intima-media thickness (IMT)." | 9.10 | Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. ( Bondjers, G; Hulthe, J; Olofsson, SO; Schmidt, C; Wiklund, O; Wikstrand, J, 2002) |
| "To study effects of fosinopril on a 24-h profile of blood pressure (BP) in hypertensive patients with obesity and hypercholesterolemia." | 5.11 | [Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia]. ( Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM, 2005) |
| " The aim of this study was to test the hypothesis that the beta-blocker metoprolol succinate controlled release/extended release (CR/XL), when given to patients with hypercholesterolemia on concomitant lipid-lowering therapy, provides an additional antiatherosclerotic effect to that provided by the statins, measured as carotid intima-media thickness (IMT)." | 5.10 | Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. ( Bondjers, G; Hulthe, J; Olofsson, SO; Schmidt, C; Wiklund, O; Wikstrand, J, 2002) |
| "In a sulfinpyrazone-treated group 3 out of 8, and in a metoprolol-treated group 2 out of 5 animals died." | 1.27 | Sudden death related to advanced coronary atherosclerosis in mini-pigs: influence of some drugs. ( Jacobsson, L; Lundholm, L; Wingren, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchan, M | 1 |
| Sillence, D | 1 |
| Wikstrand, J | 2 |
| Berglund, G | 1 |
| Hedblad, B | 1 |
| Hulthe, J | 2 |
| Vershinina, AM | 1 |
| Gapon, LI | 1 |
| Veber, EE | 1 |
| Popova, SN | 1 |
| Pliusnin, AV | 1 |
| Jacobsson, L | 1 |
| Lundholm, L | 1 |
| Wingren, G | 1 |
| Wiklund, O | 1 |
| Schmidt, C | 1 |
| Olofsson, SO | 1 |
| Bondjers, G | 1 |
| MacMahon, SW | 1 |
| Macdonald, GJ | 1 |
3 trials available for metoprolol and Elevated Cholesterol
| Article | Year |
|---|---|
Antiatherosclerotic effects of beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carotid Arteries; Coronary Artery Disease; | 2003 |
[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Sc | 2005 |
Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carotid Artery Diseases; Cholesterol, LDL; Delayed-Acti | 2002 |
3 other studies available for metoprolol and Elevated Cholesterol
| Article | Year |
|---|---|
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defib | 2011 |
Sudden death related to advanced coronary atherosclerosis in mini-pigs: influence of some drugs.
Topics: Animals; Cholesterol; Coronary Circulation; Coronary Disease; Coronary Vessels; Creatine Kinase; Dea | 1984 |
Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study.
Topics: Adult; Age Factors; Antihypertensive Agents; Australia; Blood Pressure; Cholesterol; Cholesterol, HD | 1986 |